Non Small Cell Lung Cancer Market Size And Share

  • Report Code : TIPRE00026054
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Principales conclusions et analyse des parts de marché du cancer du poumon non à petites cellules d'ici 2025-2031

Buy Now

Non-small Cell Lung Cancer Market Report Non-small Cell Lung Cancer Market Scope and Analysis Non-small Cell Lung Cancer Market Size and Share

Non-small Cell Lung Cancer Market Report Analysis

Non-small Cell Lung Cancer Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • Eli Lilly And Company
  • AstraZeneca
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • ONO PHARMACEUTICAL CO., LTD.
  • Boehringer Ingelheim International GmbH

Regional Overview

  • Amérique du Nord
  • Europe
  • Asie-Pacifique
  • Amérique du Sud et centrale
  • Moyen-Orient et Afrique

Market Segmentation

By Type de cancer
  • adénocarcinome
  • carcinome épidermoïde et carcinome à grandes cellules
By Thérapie
  • Bevacizumab
  • Dabrafenib/Trametinib
  • chlorhydrate d'erlotinib
  • osimertinib et autres
By Canal de distribution
  • pharmacies hospitalières
  • pharmacies de détail
  • pharmacies en ligne et autres
By Géographie
  • Amérique du Nord
  • Europe
  • Asie-Pacifique
  • Amérique du Sud et Centrale